An article from Medpagetoday.
For some reason my hyperlinks don't always come over to Malecare.
An article from Medpagetoday.
For some reason my hyperlinks don't always come over to Malecare.
Never mind about the link, go figure.
Also, if anyone can get the full article, please post.
Here is an excerpt from the OPs link:
"Magnetic resonance (MR)‐guided adaptive stereotactic body radiotherapy (SBRT) for prostate cancer was associated with significantly lower rates of acute genitourinary and gastrointestinal toxicities compared with CT-guided non-adaptive SBRT, according to a systematic review and meta-analysis.
Across 29 prospective studies involving over 2,500 patients, the risk of short‐term genitourinary side effects was reduced by 44% with MR-guided adaptive SBRT versus CT-guided SBRT (OR 0.56, 95% CI 0.33-0.97, P=0.04), while the risk of short‐term gastrointestinal side effects was reduced by 60% (OR 0.40, 95% CI 0.17-0.96, P=0.04), reported Jonathan Leeman, MD, of the Dana-Farber Cancer Institute in Boston, and colleagues."
medpagetoday.com/hematology...
I believe those of us who have utilized such technology will attest with the conclusion regarding less side effects.
I had SBRT treatment at UCLA with ViewRay MRI adaptive SBRT technology in September 2022, and my personal experience regarding the side effects from that technology was no side effects to speak of so far.
Currently, ViewRay is going through bankruptcy, and I sure hope their technology is able to survive, because I think it has the potential to help a lot of people with minimal side effects.